AdvaMed submitted comments to the U.S. Food and Drug Administration in response to FDA’s discussion paper on the regulation of generative AI-enabled medical devices (Docket No. FDA-2026-N-7874). The ...
WASHINGTON—AdvaMed, the Medtech Association, encouraged the U.S. Food and Drug Administration (FDA) to build on its existing ...
BOSTON—AdvaMed, the Medtech Association, concluded The MedTech Conference 2026, convening more than 4,470 attendees from 2,050 companies from 40 countries for the global medtech industry’s premier ...
BOSTON—AdvaMed, the Medtech Association, brought together innovators and industry leaders at The MedTech Conference 2026, ...
BOSTON—AdvaMed, the Medtech Association, convened the 13th Annual Symposium on Pediatric Device Innovation on October 18 at ...
BOSTON—AdvaMed, the Medtech Association, today announced Scott Garrett as the 2026 recipient of the AdvaMedDx Lifetime of ...
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the Medtech Association, welcomed the executive order from President ...
Paradromics Inc., a neurotechnology company developing high-data-rate brain-computer interfaces to restore and enhance human ...
WASHINGTON, D.C.—AdvaMed, the Medtech Association, today announced that its Digital Health Tech Board of Directors has approved voluntary Data Access Principles & Best Practices to help medical ...
Download the complete best practices document outlining the framework and recommendations developed by AdvaMed’s Digital Health Tech division. Protecting patient privacy and ensuring responsible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results